Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Repligen Corp RGEN

Technology Scientific & Technical Instruments
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises: filtration (including fluid management); chromatography; process analytics, and proteins. Its filtration products are used in process development and process scale (clinical and commercial... see more

Recent & Breaking News (NDAQ:RGEN)

Repligen Selects Purolite Life Sciences as Commercial Partner for New High Performance Ligand

GlobeNewswire June 28, 2018

Repligen Announces Agreement with Navigo Proteins for the Exclusive Co-Development of Next Generation Affinity Ligands

GlobeNewswire June 27, 2018

Report: Exploring Fundamental Drivers Behind Matthews International, Raytheon, JetBlue Airways, Repligen, Becton, Dickinson, and Macy's — New Horizons, Emerging Trends, and Upcoming Developments

GlobeNewswire June 11, 2018

Repligen to Present at the William Blair 2018 Growth Stock Conference

GlobeNewswire May 30, 2018

Repligen to Present at Jefferies 2018 Global Healthcare Conference

GlobeNewswire May 23, 2018

Repligen to Participate in 15th Annual Craig-Hallum Institutional Investor Conference

GlobeNewswire May 17, 2018

Repligen Reports First Quarter 2018 Financial Results

GlobeNewswire May 8, 2018

Repligen to Report First Quarter 2018 Financial Results

GlobeNewswire April 30, 2018

Analysis: Positioning to Benefit within Clearwater Paper, Energous, MINDBODY, Agilysys, Repligen, and Unit — Research Highlights Growth, Revenue, and Consolidated Results

GlobeNewswire March 20, 2018

Repligen Announces Market Launch of OPUS® 80R, Reinforces Technology Leadership in Pre-Packed Chromatography

GlobeNewswire March 20, 2018

56 Biggest Movers From Yesterday

Benzinga.com  February 23, 2018

45 Stocks Moving In Thursday's Mid-Day Session

Benzinga.com  February 22, 2018

Repligen Reports Fourth Quarter 2017 Financial Results, Provides Guidance for 2018

GlobeNewswire February 22, 2018

Repligen Corporation to Host Earnings Call

Accesswire February 22, 2018

Repligen to Report Fourth Quarter and Full Year 2017 Financial Results

GlobeNewswire February 16, 2018

Repligen To Present at 36th Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 29, 2017

Repligen Reports Third Quarter 2017 Financial Results

GlobeNewswire November 9, 2017

Repligen Corporation to Host Earnings Call

Accesswire November 9, 2017

Repligen Extends Long Term Supply Agreement with Purolite for Protein A Ligands

GlobeNewswire November 7, 2017

Repligen to Report Third Quarter 2017 Financial Results

GlobeNewswire November 1, 2017